GPR137C

Across TCGA pan-cancer cohorts, GPR137C Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GPR137C data layer compared with 28 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher GPR137C Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GPR137C expression acts as an unfavorable survival marker.

ESCA, LIHC, and PRAD are the cancer types where GPR137C Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.136	0.703	<.001	24	view →
LIHC	DFS	Median	All	0.044	0.553	<.001	12	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

GPR137C–ESCA (OS)

Open the ESCA breakdown →